Continuous Cytostatic Effects of BCR-ABL Tyrosine Kinase Inhibitors (TKIs) after Washout in Human Leukemic K562 Cells-Reference-Cited by-同舟云学术

Continuous Cytostatic Effects of BCR-ABL Tyrosine Kinase Inhibitors (TKIs) after Washout in Human Leukemic K562 Cells

Published:2019-11-01 Issue:11 Volume:42 Page:1805-1813
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Aoyama Tsuyoshi¹,Shibayama Yoshihiko²,Furukawa Tatsuhiko³,Sugawara Mitsuru¹,Takekuma Yoh¹

Affiliation:

1. Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University

2. Department of Drug Fomulation, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido

3. Department of Molecular Oncology, Graduate School Medical and Dental Sciences, Kagoshima University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/42/11/42_b19-00185/_pdf

Reference34 articles.

1. 1) Nowell PC. The minute chromosome (Ph1) in chronic granulocytic leukemia. Ann. Hematol., 8, 65–66 (1962).

2. 2) Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 290–293 (1973).

3. 3) Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer, 5, 172–183 (2005).

4. 4) Kujawski LA, Talpaz M. The role of interferon-alpha in the treatment of chronic myeloid leukemia. Cytokine Growth Factor Rev., 18, 459–471 (2007).

5. 5) Larson RA, Druker BJ, Guilhot F, O’Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood, 111, 4022–4028 (2008).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory Effect of Cell Phones Against Human Breast Cancer and Myeloid Leukemia Cells Proliferation in Culture Media;Acta Medica Nicomedia;2023-06-30

2. Reply to Comment on low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study;Cancer;2020-10-23

3. Detection of Two Genotoxic Impurities in Drug Substance and Preparation of Imatinib Mesylate by LC–MS/MS;Chromatographia;2020-05-12